In this interview we speak to Amy Mathers about her research on the role of hospital plumbing in the evolution and exchange of genes of drug resistance.
Browsing: Research > Clinical
Researchers at Stanford University School of Medicine have reported that the most common origin of bloodstream infections, during a hospital stay, as a consequence of the patient’s own gut.
Scientists, led by the National University of Singapore and the University of Glasgow, have used the term ‘lateral transduction’ to describe a novel, dangerously-potent mechanism of bacteriophage-induced genetic transduction.
In this infographic we take a look at the estimated burden of healthcare-associated infections in acute care hospitals across Europe.
A pioneering treatment, an antibody termed PRN100, is to be given to a patient with sporadic Creutzfeldt-Jakob disease for the first time.
In this interview with Trisha Peel from Monash University, she explains the issues surrounding device-related infections in addition to discussing some promising new approaches to diagnosis and treatment.
In this interview, we speak to to Keith Kaye, Principle Investigator of the RESTORE-1 trial assessing relebactam in combination with imipenem (IMI/REL), about the trial’s results and the implications these have for clinicians in ‘real world’ settings.
Nearly half of prescriptions for antibiotics were written without an infection-related diagnosis, according to a study of 509,534 prescriptions reported at IDWeek today.
During the current opioid crisis, only one-third of youths diagnosed with opioid use disorder were tested for hepatitis C, according to the results of a large national sample presented at IDWeek.
The US FDA has approved Paratek Pharmaceuticals’ antibiotic Nuzyra™ (omadacycline) for the treatments of adults with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.